IMMIX BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $202.0K | $18.2M | $17.6M |
| FY2022 | $1.7M | $14.9M | $13.4M |
| FY2023 | $3.7M | $19.9M | $17.5M |
| FY2024 | $9.7M | $22.9M | $17.7M |
| FY2025 | $11.0M | $104.8M | $93.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $202.0K | $18.2M | $17.6M |
| FY2022 | $1.7M | $14.9M | $13.4M |
| FY2023 | $3.7M | $19.9M | $17.5M |
| FY2024 | $9.7M | $22.9M | $17.7M |
| FY2025 | $11.0M | $104.8M | $93.9M |